We wondered if the level of activation or exhaustion of CD8+ T cells was affected by NRP1 and could thus account for differences between genotypes, but found no difference in PD-1, CD25, CD69 or CD44 expression levels on CD8+ T cells 15 days post tumor injection (Fig. 2e). This evidence concerns the gene CD69 and neoplasm.